{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:57Z","timestamp":1792892097237,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008628","name":"Ministry of Electronics and Information technology","doi-asserted-by":"publisher","award":["5(1)\/2021-NANO"],"award-info":[{"award-number":["5(1)\/2021-NANO"]}],"id":[{"id":"10.13039\/501100008628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012099","name":"Indian Institute of Technology Guwahati","doi-asserted-by":"publisher","award":["5\/3\/8\/20\/2019-ITR"],"award-info":[{"award-number":["5\/3\/8\/20\/2019-ITR"]}],"id":[{"id":"10.13039\/501100012099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118029","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:16:00Z","timestamp":1777673760000},"page":"118029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt\/\u03b2-catenin signaling"],"prefix":"10.1016","volume":"250","author":[{"given":"Arisha","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5019-0936","authenticated-orcid":false,"given":"Siddhartha Sankar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118029_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","article-title":"The epithelial\u2013mesenchymal transition: new insights in signaling, development, and disease","volume":"172","author":"Lee","year":"2006","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118029_b0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial\u2013mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118029_b0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jmcb\/mjy041","article-title":"miR-221\/222 activate the Wnt\/\u03b2-catenin signaling to promote triple-negative breast cancer","volume":"10","author":"Liu","year":"2018","journal-title":"J. Mol. Cell Biol."},{"issue":"300","key":"10.1016\/j.bcp.2026.118029_b0030","article-title":"Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs","volume":"1","author":"Yang","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-38039-x","article-title":"Engineering protein-based therapeutics through structural and chemical design","volume":"14","author":"Ebrahimi","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/d41573-024-00001-x","article-title":"2023 FDA approvals","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2026.118029_b0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3892\/ol.2021.12699","article-title":"Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway","volume":"21","author":"Huang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2026.118029_b0050","article-title":"A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach","volume":"16","author":"Kothari","year":"2024","journal-title":"Cureus."},{"key":"10.1016\/j.bcp.2026.118029_b0055","unstructured":"Biotherapeutics: Revolutionizing Medicine \u2013 Institute of Life Sciences, BBSR, Department of Biotechnology [Internet]. [cited 2025 Sep 22]. Available from: https:\/\/www.ils.res.in\/biotherapeutics-revolutionizing-medicine\/."},{"issue":"10","key":"10.1016\/j.bcp.2026.118029_b0060","first-page":"10593","article-title":"Inhibitory effects of pigment epithelium-derived factor on epithelial-mesenchymal transition, migration and invasion of breast cancer","volume":"10","author":"Zhou","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118029_b0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jcmgh.2015.06.006","article-title":"Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt\/\u03b2-catenin Signaling in the Liver","volume":"1","author":"Protiva","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118029_b0070","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/jcb.25956","article-title":"Role of Wnt co-receptor LRP6 in triple negative breast cancer cell migration and invasion","volume":"118","author":"Ma","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"119","key":"10.1016\/j.bcp.2026.118029_b0075","article-title":"Targeting the RAR\u03b1\u2013Gankyrin\u2013PI3K axis with retinoid analogs to modulate autophagy in breast cancer cells: Computational insights and experimental validation","volume":"1","author":"Khanra","year":"2025","journal-title":"Comput Biol Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-021-04130-7","article-title":"Correlation AnalyzeR: functional predictions from gene co-expression correlations","volume":"22","author":"Miller","year":"2021","journal-title":"BMC Bioinf."},{"issue":"102","key":"10.1016\/j.bcp.2026.118029_b0085","article-title":"Multi-targeting TACE\/ADAM17 and gamma-secretase of notch signalling pathway in TNBC via drug repurposing approach using Lomitapide","volume":"1","author":"Sen","year":"2023","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-023-00578-5","article-title":"The immune-adjunctive potential of recombinant LAB vector expressing murine IFN\u03bb3 (MuIFN\u03bb3) against Type A Influenza Virus (IAV)infection","volume":"15","author":"Yadav","year":"2023","journal-title":"Gut Pathog."},{"key":"10.1016\/j.bcp.2026.118029_b0095","doi-asserted-by":"crossref","unstructured":"Arora N, Ghosh SS. Protein Therapeutics from Monolayer to Spheroids- A Model for Preclinical Investigations. Journal of Cancer Immunology,; Volume 2(Issue 2):40-43. 2020 Aug 4;Volume 2(Issue 2):40\u20133. doi:10.33696\/CANCERIMMUNOL.2.013.","DOI":"10.33696\/cancerimmunol.2.013"},{"issue":"12","key":"10.1016\/j.bcp.2026.118029_b0100","article-title":"Therapeutic Targeting of MELK by Repurposed Drugs Netarsudil and Dutasteride Suppresses Triple-Negative Breast Cancer Cell Progression: Evidence From Molecular Simulations and Functional Validations","volume":"8","author":"Arora","year":"2025","journal-title":"Adv Ther (Weinh)."},{"key":"10.1016\/j.bcp.2026.118029_b0105","unstructured":"Membrane stripping for western blot | Abcam [Internet]. [cited 2025 Sep 22]. Available from: https:\/\/www.abcam.com\/en-us\/technical-resources\/guides\/western-blot-guide\/membrane-stripping-for-western-blot?srsltid=AfmBOop3SbDPGNdB63QDQqPOKlJ0QixVOsUW7d4bNej7GTq6zZEbanxB."},{"issue":"5","key":"10.1016\/j.bcp.2026.118029_b0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jcmgh.2015.06.006","article-title":"Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt\/\u03b2-catenin Signaling in the Liver","volume":"1","author":"Protiva","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118029_b0115","first-page":"257","article-title":"Expression and Purification of Recombinant Proteins Using the pET System","volume":"14","author":"Mierendorf","year":"1998","journal-title":"Methods Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/bioinformatics\/btw554","article-title":"PDB2CD: a web-based application for the generation of circular dichroism spectra from protein atomic coordinates","volume":"33","author":"Mavridis","year":"2017","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12195-021-00694-9","article-title":"Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis","volume":"15","author":"Buyuk","year":"2022","journal-title":"Cell. Mol. Bioeng."},{"issue":"5","key":"10.1016\/j.bcp.2026.118029_b0130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s12276-020-0440-y","article-title":"Destabilization of \u03b2-catenin and RAS by targeting the Wnt\/\u03b2-catenin pathway as a potential treatment for triple-negative breast cancer","volume":"52","author":"Ryu","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118029_b0135","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"986","key":"10.1016\/j.bcp.2026.118029_b0140","article-title":"Small-molecule inhibitors of WNT signalling in cancer therapy and their links to autophagy and apoptosis","volume":"5","author":"Menon","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"289","key":"10.1016\/j.bcp.2026.118029_b0145","article-title":"Chemotherapeutic drugs induce oxidative stress associated with DNA repair and metabolism modulation","volume":"15","author":"Zhang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118029_b0150","article-title":"Overview of recent advances in metastatic triple negative breast cancer. World","author":"O\u2019Reilly","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118029_b0160","unstructured":"Combinations Targeting PI3K\/AKT\/mTOR and MAPK\/ERK Pathways Are Under Study in Endometrial Cancer | OncLive [Internet]. [cited 2025 Sep 23]. Available from: https:\/\/www.onclive.com\/view\/combinations-targeting-pi3k-akt-mtor-and-mapk-erk-pathways-are-under-study-in-endometrial-cancer."},{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1158\/2767-9764.CRC-22-0260","article-title":"Phase I Study of mTORC1\/2 Inhibitor Sapanisertib (CB-228\/TAK-228) in Combination with Metformin in Patients with mTOR\/AKT\/PI3K Pathway Alterations and Advanced Solid Malignancies","volume":"4","author":"Subbiah","year":"2024","journal-title":"Cancer Res. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118029_b0170","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40264-018-0780-x","article-title":"Safety and Tolerability of c-MET Inhibitors in Cancer","volume":"42","author":"Puccini","year":"2019","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.bcp.2026.118029_b0180","first-page":"405","article-title":"Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt\/\u03b2-catenin signaling regulation","volume":"44","author":"Shome","year":"2021","journal-title":"Cellular oncology (Dordrecht, Netherlands)."},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118029_b0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1476-4598-9-236","article-title":"Convergence between Wnt-\u03b2-catenin and EGFR signaling in cancer","volume":"9","author":"Hu","year":"2010","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2026.118029_b0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of \u03b2-catenin, and enhanced tumor cell invasion","volume":"4","author":"Lu","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118029_b0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118029_b0205","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1038\/oncsis.2017.14","article-title":"Wnt signaling in triple-negative breast cancer","volume":"6","author":"Pohl","year":"2017","journal-title":"Oncogenesis."},{"issue":"7","key":"10.1016\/j.bcp.2026.118029_b0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bcp.2026.118029_b0215","article-title":"Targeting Wnt\/\u03b2-Catenin Pathway for Drug Therapy","volume":"1","author":"Liu","year":"2020","journal-title":"Med Drug Discov."},{"issue":"14","key":"10.1016\/j.bcp.2026.118029_b0220","article-title":"Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer","volume":"28","author":"Shen","year":"2023","journal-title":"Front Pharmacol."},{"issue":"193","key":"10.1016\/j.bcp.2026.118029_b0225","article-title":"The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target","volume":"1","author":"Abooshahab","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118029_b0230","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.21873\/anticanres.13473","article-title":"The Role of PEDF in Pancreatic Cancer","volume":"39","author":"Ansari","year":"2019","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.bcp.2026.118029_b0235","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1007\/s11033-019-04965-7","article-title":"Deciphering therapeutic potential of PEGylated recombinant PTEN-silver nanoclusters ensemble on 3D spheroids","volume":"46","author":"Arora","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118029_b0240","first-page":"391","article-title":"Oxidative stress response induced by chemotherapy in leukemia treatment (Review)","volume":"8","author":"Zhang","year":"2018","journal-title":"Mol Clin Oncol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118029_b0245","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/acsptsci.4c00370","article-title":"Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy","volume":"7","author":"Patra","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118029_b0250","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:38:14Z","timestamp":1792888694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S000629522600362X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118029","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant pigment epithelium-derived factor reverses epithelial-to-mesenchymal transition (EMT) and impedes proliferation of triple-negative breast cancer cells through downregulation of Wnt\/\u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118029"}}